Sector--
Established Date16/06/2003
Listing Date19/05/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees199
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressUppsalalaan 17, 3584 CT Utrecht, The Netherlands
Business
IntroductionMerus N.V. was established under Dutch law on June 16, 2003. The company is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapies. Its pipeline of full-length human bispecific antibody candidates, which they call biclonics, is generated from their technology platform.
